<DOC>
	<DOC>NCT00937014</DOC>
	<brief_summary>The purpose of this clinical trial is to assess growth (rate of weight gain in grams per day) of infants fed an infant formula with a whey isolate enriched with lactoferrin, during the first four months of life as compared to infants fed a standard infant formula.</brief_summary>
	<brief_title>Assessment of Growth of Infants Fed a New Formula</brief_title>
	<detailed_description />
	<mesh_term>Lactoferrin</mesh_term>
	<criteria>Healthy newborn infant Fullterm (&gt;37 weeks gestation) Birth weight between &gt; 2500 and &lt; 4500 g Infant's mother has elected not to breastfeed and baby has been exclusively formula fed a minimum 3 days prior to enrollment Tolerating a cows milk based formula for at least 3 days Study explained and written information provided with Parent/Caregiver demonstrating understanding of the given information Informed consent signed (Parent/Legal representative) Parent/Caregiver has a working freezer Lives within 45 minutes of a study site Congenital illness or malformation that may affect infant feeding and/or normal growth Suspected or known allergy to cow's milk protein Significant prenatal and/or postnatal disease Any readmission to hospital (except for hyperbilirubinemia) prior to enrollment Infant has received oral or intravenous antibiotic therapy in the 10 days prior to enrollment Infant receiving prescription medication (with exception of treatment for thrush) or frequent use of over the counter medications except vitamin and mineral supplements Infant currently participating in another clinical study Infant's family who in the Investigator's assessment cannot be expected to comply with the protocol</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Days</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>infant formula</keyword>
	<keyword>growth</keyword>
	<keyword>weight</keyword>
</DOC>